Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
RG6289 / Roche
NCT06402838: A Study to Evaluate the Safety and Biomarker Effects of RO7269162 in Participants at Risk for or at the Prodromal Stage of Alzheimer's Disease (AD)	Recruiting	2	245	Europe, RoW	RO7269162, Placebo	Hoffmann-La Roche	Alzheimer's Disease	05/27	05/27
NCT06733298: A Study Investigating [14C]-Labeled RO7269162 in Healthy Male Participants	Not yet recruiting	1	10	NA	[ 14C]-labeled RO7269162	Hoffmann-La Roche	Healthy Volunteers	01/25	02/25